По вашему запросу найдено документов: 318

Страница 1 из 32

THE RELATIONSHIP OF THE IMMUNE RESPONSE MEDIATOR GENES' POLYMORPHIC VARIANTS WITH THE METHOTREXATE EFFICACY IN JUVENILE IDIOPATHIC ARTHRITIS
NAZAROVA, L.SH., DANILKO, K.V., MALIEVSKY, V.A., KARIMOV, D.O., BAKIROV, A.B., VIKTOROVA, T.V. (2020)
, PADI4 rs2240336) variants with the methotrexate efficacy in juvenile idiopathic arthritis (JIA
Адаптация и валидация шкалы непереносимости метотрексата MISS у детей с ювенильным идиопатическим артритом: одномоментное поперечное исследование
Customization and validation of the Methotrexate Intolerance Severity Score in children with juvenile idiopathic arthritis: a cross-sectional study
Жуков, С.С., Малиевский, В.А., Леонова, А.С., Zhukov, S.S., Malievskiy, V.A., Leonova, A.S. (2022)
опросник MISS. Цель. Валидация и адаптация опросника MISS (Methotrexate Intolerance Severity Score) в
РОЛЬ ВАРИАНТОВ ГЕНЕТИЧЕСКИХ ПОЛИМОРФИЗМОВ В ПРОГНОЗИРОВАНИИ ЭФФЕКТИВНОСТИ ТЕРАПИИ МЕТОТРЕКСАТОМ ПРИ ЮВЕНИЛЬНОМ АРТРИТЕ
THE ROLE OF VARIANTS OF GENETIC POLYMORPHISMS IN PREDICTING THE EFFECTIVENESS OF METHOTREXATE THERAPY IN JUVENILE ARTHRITIS
Казанцева, С.Р., Назарова, Л.Ш., Жуков, С.С., Малиевский, В.А., Викторова, Т.В., Kazantseva, S.R., Nazarova, L.Sh., Zhukov, S.S., Malievsky, V.A., Viktorova, T.V. (2021)
THE ROLE OF VARIANTS OF GENETIC POLYMORPHISMS IN PREDICTING THE EFFECTIVENESS OF METHOTREXATE
СРАВНЕНИЕ ЭФФЕКТИВНОСТИ И БЕЗОПАСНОСТИ БАЗИСНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ И ГЕННО-ИНЖЕНЕРНЫХ БИОЛОГИЧЕСКИХ ПРЕПАРАТОВ ПРИ ПСОРИАТИЧЕСКОМ АРТРИТЕ
COMPARISON OF EFFICACY AND SAFETY OF BASIC ANTI-INFLAMMATORY DRUGS AND GENETICALLY ENGINEERED BIOLOGICAL PRODUCTS IN PSORIATIC ARTHRITIS
ХИСМАТУЛЛИНА, З.Р., КОРЕШКОВА, К.М., ЗАЦЕПИЛОВА, Г.А., ДОРОЖКО, Л.А., HISMATULLINA, Z.R., KORESHKOVA, K.M., ZATSEPILOVA, G.A., DOROZHKO, L.A., GLIMNUROVA, L.M., ГЛИМНУРОВА Л.М. (2021)
COMPARISON OF EFFICACY AND SAFETY OF BASIC ANTI-INFLAMMATORY DRUGS AND GENETICALLY ENGINEERED
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
Alexeeva, E, Horneff, G., Dvoryakovskaya, T., Denisova, R., Nikishina, I., Zholobova, E., Malievskiy, V., Santalova, G., Stadler, E., Balykova, L., Spivakovskiy, Y., Kriulin, I., Alshevskaya, A., Moskalev, A. (2021)
of remission. The aim of this study was to evaluate the effectiveness of early etanercept+methotrexate (ETA
Микробиота кишечника у детей с ювенильным идиопатическим артритом
Gut microbiota and methotrexate in children with juvenile idiopathic arthritis
Zhukov, S.S., Malievsky, V.A., Nizhevich, A.A., Жуков, С. С., Малиевский, В. А., Нижевич, А. А (2023)
Gut microbiota and methotrexate in children with juvenile idiopathic arthritis
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
Burtness, B., Haddad, R., Dinis, J., Trigo, J., Yokota, T, De Souza Viana, L., Romanov, I., Vermorken, J., Bourhis, J., Tahara, M., Martins Segalla, J.G., Psyrri, A., Vasilevskaya, I., Nangia, C.S., Chaves-Conde, M., Kiyota, N., Homma, A., Holeckova, P., Del Campo, J.M., Asarawala, N., Nicolau, U.R., Rauch, D., Even, C., Wang, B., Gibson, N., Ehrnrooth, E., Harrington, K., Cohen, E.E.W. (2019)
has shown efficacy in recurrent or metastatic HNSCC. Objective: To assess whether afatinib therapy
PADI4 GENE POLYMORPHISM AS A PREDICTOR OF RESPONSE TO METHOTREXATE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
Nazarova, L.S., Danilko, K.V., Malievsky, V.A., Viktorova, T.V. (2016)
Background: Methotrexate (MTX) is the most widely used disease-modifying anti-rheumatic drug
METHODOLOGICAL APPROACHES TO THE USE OF THE REGISTER OF CHILDREN WITH JUVENILE ARTHRITIS AT THE LEVEL OF SPECIALIZED MEDICAL CARE
Malievsky, V.A., Malievsky, O.A., Akhmetshin, R.Z., Gareeva, G.R., Zhukov, S.C., Pervushina, E.P., Nuriakhmetova, A.J., Nurgalieva, L.R., Khasanova, A.A., МАЛИЕВСКИЙ ВИКТОР АРТУРОВИЧ, МАЛИЕВСКИЙ О.А., АХМЕТШИН Р.З., ГАРЕЕВА Г.Р., ЖУКОВ С.С., ПЕРВУШИНА Е.П., НУРИАХМЕТОВА А.Ж., НУРГАЛИЕВА Л.Р., ХАСАНОВА А.А. (2019)
with JA is assessment various aspects of the efficacy and safety of biologics in comparison
EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodok, J., Skorodok, J., Malievsky, O., Rosenfeld, R.G., Zadik, Z., Koren, R., Vander, S., Hart, G., Raduk, D. (2016)
EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH

Страница 1 из 32

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год